MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. - Wikidata - awgldk - TriplyDB

MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression.

MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression.

http://www.wikidata.org/entity/Q37970478

about

The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer Tumour progression and metastasis Epithelial-Mesenchymal Transition and Breast Cancer The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145 Causes of genome instability: the effect of low dose chemical exposures in modern society MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance The Hydroalcoholic Extract of Matricaria chamomilla Suppresses Migration and Invasion of Human Breast Cancer MDA-MB-468 and MCF-7 Cell Lines.Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer.The role of epithelial plasticity in prostate cancer dissemination and treatment resistance Circulating miR-221 expression level and prognosis of cutaneous malignant melanoma.Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.Friend or foe: Endoplasmic reticulum protein 29 (ERp29) in epithelial cancer.MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell.Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alström syndromes.Human miRNome profiling in colorectal cancer and liver metastasis development.High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.Snail heterogeneity in clear cell renal cell carcinoma.Population Heterogeneity in the Epithelial to Mesenchymal Transition Is Controlled by NFAT and Phosphorylated Sp1.Connecting the dots: chromatin and alternative splicing in EMT.A comparison of epithelial-to-mesenchymal transition and re-epithelialization Microenvironmental regulation of epithelial-mesenchymal transitions in cancer MicroRNAs networks in thyroid cancers: focus on miRNAs related to the fascin.Essential genes in thyroid cancers: focus on fascin.MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo The relevance of the TGF-β Paradox to EMT-MET programs Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties.Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model.Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition.MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4.The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.

P2860

Q21261256-74BDFA1F-7097-432C-AE7A-6152CC54FCE8 Q26766468-9DB5B33E-22FF-4640-927B-AEC329071AC4 Q26773055-5395338D-C283-4653-8FFA-DF319FA8D4E4 Q26865458-4C51AB49-0A1F-423B-BE29-890E7229FAFB Q28069105-918CF5F0-FC69-4D89-A1E4-21E1FF3B6F6C Q28070337-F7AA65B9-22BC-44BD-B493-A478BBA33824 Q28284329-FA4639DC-A001-462A-87E8-60FD3A953B4C Q28388277-8F5066F7-141B-4944-A78D-78CB6DABC1DB Q28538690-D23CAE30-BAD5-4059-B269-11F6C7D94065 Q32181214-5AA87781-B17D-455D-8B46-AB201A1ADFE9 Q33700623-8A3FFBEA-AB59-4924-A0B2-F251E77E8FB9 Q34448246-570E78D7-0E4B-493B-90EC-E92FD9BB35AA Q34505037-145E58A3-1106-45E3-84CE-18CA9499242F Q34655391-7C41F292-E0F5-4E49-B8C7-8DB2DC7957C8 Q34779925-B1B689B5-66F9-460F-A6F2-22E57C2D529D Q34976152-43159FD4-D0CC-4424-95EF-688363F01220 Q35086896-B89D81BC-1062-44F8-922F-B601AAFCE6A0 Q35093171-637A4BE0-911C-4547-92DC-732526E5CBA3 Q35100466-3ECD406D-4252-48A0-A7A4-C52565A89AE7 Q35814028-0A01E009-A5F2-4D3D-B937-FA263F0727AF Q35842588-B7291E28-D418-4ADE-945F-E021F84023AA Q35908698-2DE235A3-D629-47E2-925D-140370C02BF5 Q35948243-5AF61112-D30A-4C0B-B8EA-77F7E51D6EE2 Q36233870-7E962955-4143-4D3C-AF59-EDACCD0DA0BD Q36441240-04C0F1A2-B0E8-4E3B-9B57-A4FE71E7FE1D Q36678367-0A9F2DB6-7649-400D-B974-B25E48265C6D Q36831337-682466FF-ED61-45C7-9A77-85E39648E1ED Q37071353-B8A0374D-7E09-4FB8-9C40-4F1816B09866 Q37071818-C4DA208C-0729-4825-8C7B-18CD5809F015 Q37086059-96399609-7CD6-4426-AF31-5E87D0D3923E Q37107787-0E581BCE-2466-4562-BEE2-46079D98900D Q37118399-581D11DD-C8B7-42A0-8CE0-6B00286948CE Q37152198-A658E757-6F94-44A6-908E-F206A7FBE2ED Q37180271-D7B8BB6D-7208-41EA-A563-FA7050CF3BEC Q37282882-304539F1-E62E-4283-8D27-8CA89E61481F Q37304724-F4BC5996-C72A-41B0-A359-A7031A963FB1 Q37308115-55E710BC-CE75-40BF-8B83-73A6AD638165 Q37504774-CB5D4E1B-0AE6-44DD-8A08-EBEF4D4B3617 Q37706322-EF14979C-AA19-4212-874B-28850D6D2BDA Q38021354-E1781D08-79AE-4093-BD52-0A1B32891DFD

P2860

MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression.

http://www.wikidata.org/entity/Q37970478

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

MicroRNAs: critical regulators ...... n (MET) in cancer progression.

@en

MicroRNAs: critical regulators of epithelial to mesenchymal

@nl

type

label

MicroRNAs: critical regulators ...... n (MET) in cancer progression.

@en

MicroRNAs: critical regulators of epithelial to mesenchymal

@nl

prefLabel

MicroRNAs: critical regulators ...... n (MET) in cancer progression.

@en

MicroRNAs: critical regulators of epithelial to mesenchymal

@nl

P1433

Q37970478-2353849F-3F10-41EF-949F-F8B171A81F9C

P1476

Q37970478-471B9CA6-0FBD-4FE0-9A21-B23BC9AE7323

P2093

Q37970478-0E9FD467-5AEE-40FD-9630-417D30E26128

Q37970478-4B3DA236-8F77-43CC-B725-0E89D99B44BE

Q37970478-87910F61-ABFA-4156-BF8F-600223B1BDF8

Q37970478-F2296151-B524-453F-ADF4-C8AECBEFA94C

P2860

Q37970478-04BFD8BF-5199-49CB-B9DF-F47A6BC806BD

Q37970478-0652F56A-81C2-4CC3-A045-4AFE4F022493

Q37970478-06DBFFB3-A5EF-47B0-AA47-E4AA31859A06

Q37970478-0932D63D-3A19-44CC-9418-5D4D7861C89E

Q37970478-0E82560E-9E7A-4C91-A211-E58958194230

Q37970478-12EE6D35-6696-4EAF-A917-BD1E0A8AE86A

Q37970478-13C6B337-62BD-40D5-93BA-3E914C9584DC

Q37970478-1CBC15D2-8C88-4A5B-8F15-856157CBAE70

Q37970478-2192A01D-6B36-4A8D-9A14-2D4F243A4A31

Q37970478-38968CBB-1F43-4F25-AF05-CC004C428D32

P304

Q37970478-65BA686F-AF43-4E78-9AB0-B644E7793EC3

P31

Q37970478-EFC9D849-B8A4-4F55-A69D-44A217B96DFA

P356

Q37970478-DBFA7AA2-11A4-4E60-89DF-2FDF6C928A4A

P433

Q37970478-12180944-67B7-47AB-838B-1D3215271A12

P478

Q37970478-7223E090-04C4-44F5-938C-67050678C68B

P577

Q37970478-0DB0B9D8-B33A-4CDE-8C74-7960B7398B81

P5875

Q37970478-87740063-7013-4863-98A1-B2B2AF14267E

P698

Q37970478-D164931B-6DE5-4BC6-80D1-4303C22839B1

P921

Q37970478-60858A9B-186F-49BD-ABCD-EE1D740EC76D

P356

P1433

Biology of the Cell

P1476

MicroRNAs: critical regulators ...... n (MET) in cancer progression.

@en

P2093

Abdulkadir E Sayan

http://www.w3.org/2001/XMLSchema#string

Alex H Mirnezami

http://www.w3.org/2001/XMLSchema#string

Graham K Packham

http://www.w3.org/2001/XMLSchema#string

Marc D Bullock

http://www.w3.org/2001/XMLSchema#string

P2860

miR-200 enhances mouse breast cancer cell colonization to form distant metastases

Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island

Micro-RNA-21 regulates TGF-β-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

Identification of mammalian microRNA host genes and transcription units

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

MicroRNAs: target recognition and regulatory functions

Selective blockade of microRNA processing by Lin28

miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells

P304

3-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BOC.201100115

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51904480

http://www.w3.org/2001/XMLSchema#string

P698

22188537

http://www.w3.org/2001/XMLSchema#string

P921